"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 6 | 1 | 7 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 2 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 4 | 0 | 4 |
| 2020 | 8 | 0 | 8 |
| 2021 | 6 | 1 | 7 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2024 Feb 05; 7(2):e2356875.
-
Consumption of Health-Related Videos and Human Papillomavirus Awareness: Cross-Sectional Analyses of a US National Survey and YouTube From the Urban-Rural Context. J Med Internet Res. 2024 Jan 15; 26:e49749.
-
Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties. Ann Fam Med. 2023 Jul-Aug; 21(4):344-346.
-
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2180250.
-
Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2175541.
-
Tdap-HPV vaccination bundling in the USA: Trends, predictors, and implications for vaccine series completion. Prev Med. 2022 11; 164:107218.
-
Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the US. JAMA Health Forum. 2022 08 05; 3(8):e222706.
-
Predicting HPV vaccination among Tdap vaccinated adolescents in Georgia at the county level?. Ann Epidemiol. 2022 06; 70:74-78.
-
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties. Vaccine. 2022 02 23; 40(9):1352-1360.
-
Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults. JNCI Cancer Spectr. 2021 12; 5(6).